Urinary Bladder Neoplasms

"Urinary Bladder Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the URINARY BLADDER.

Descriptor ID	D001749
MeSH Number(s)	C04.588.945.947.960 C12.758.820.968 C12.777.829.813 C13.351.937.820.945 C13.351.968.829.707
Concept/Terms	Urinary Bladder Neoplasms Urinary Bladder Neoplasms Neoplasm, Urinary Bladder Urinary Bladder Neoplasm Neoplasms, Bladder Bladder Neoplasms Bladder Neoplasm Neoplasm, Bladder Bladder Tumors Bladder Tumor Tumor, Bladder Tumors, Bladder Urinary Bladder Cancer Urinary Bladder Cancer Cancer, Urinary Bladder Malignant Tumor of Urinary Bladder Cancer of the Bladder Bladder Cancer Bladder Cancers Cancer, Bladder Cancer of Bladder

Below are MeSH descriptors whose meaning is more general than "Urinary Bladder Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Urologic Neoplasms [C04.588.945.947]
Urinary Bladder Neoplasms [C04.588.945.947.960]
Male Urogenital Diseases [C12]
Urogenital Neoplasms [C12.758]
Urologic Neoplasms [C12.758.820]
Urinary Bladder Neoplasms [C12.758.820.968]
Urologic Diseases [C12.777]
Urinary Bladder Diseases [C12.777.829]
Urinary Bladder Neoplasms [C12.777.829.813]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urogenital Neoplasms [C13.351.937]
Urologic Neoplasms [C13.351.937.820]
Urinary Bladder Neoplasms [C13.351.937.820.945]
Urologic Diseases [C13.351.968]
Urinary Bladder Diseases [C13.351.968.829]
Urinary Bladder Neoplasms [C13.351.968.829.707]

Below are MeSH descriptors whose meaning is related to "Urinary Bladder Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Urinary Bladder Neoplasms" by people in this website by year, and whether "Urinary Bladder Neoplasms" was a major or minor topic of these publications.

Bar chart showing 74 publications over 21 distinct years, with a maximum of 9 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1999	1	0	1
2002	1	1	2
2003	1	0	1
2004	5	0	5
2005	2	0	2
2006	4	0	4
2007	6	0	6
2008	8	1	9
2009	7	1	8
2010	7	0	7
2011	5	1	6
2012	3	0	3
2013	3	1	4
2014	3	2	5
2015	1	0	1
2016	4	0	4
2017	1	1	2
2018	1	0	1
2020	1	0	1
2021	1	0	1

Below are the most recent publications written about "Urinary Bladder Neoplasms" by people in Profiles.

Shvero A, Laufer M, Zilberman DE, Winkler H, Dotan ZA, Kleinmann N. [UPPER TRACT UROTHELIAL CARCINOMA]. Harefuah. 2021 Sep; 160(9):619-624.

View in: PubMed
Hale O, Patterson K, Lai Y, Meng Y, Li H, Godwin JL, Homet Moreno B, Mamtani R. Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States. Clin Genitourin Cancer. 2021 02; 19(1):e17-e30.

View in: PubMed
Chandrasekar T, Erlich A, Zlotta AR. Molecular Characterization of Bladder Cancer. Curr Urol Rep. 2018 Nov 03; 19(12):107.

View in: PubMed
Necchi A, Joseph RW, Loriot Y, Hoffman-Censits J, Perez-Gracia JL, Petrylak DP, Derleth CL, Tayama D, Zhu Q, Ding B, Kaiser C, Rosenberg JE. Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study. Ann Oncol. 2017 Dec 01; 28(12):3044-3050.

View in: PubMed
Shore ND, Boorjian SA, Canter DJ, Ogan K, Karsh LI, Downs TM, Gomella LG, Kamat AM, Lotan Y, Svatek RS, Bivalacqua TJ, Grubb RL, Krupski TL, Lerner SP, Woods ME, Inman BA, Milowsky MI, Boyd A, Treasure FP, Gregory G, Sawutz DG, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical rAd-IFNa/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. J Clin Oncol. 2017 Oct 20; 35(30):3410-3416.

View in: PubMed
Galsky MD, Domingo-Domenech J, Sfakianos JP, Ferket BS. Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why? J Clin Oncol. 2016 Oct 10; 34(29):3495-3498.

View in: PubMed
Chandrasekar T, Evans CP. Autophagy and urothelial carcinoma of the bladder: A review. Investig Clin Urol. 2016 06; 57 Suppl 1:S89-97.

View in: PubMed
Gomella PT, Frazier H. Takotsubo stress-induced cardiomyopathy following robotic radical cystectomy. Can J Urol. 2016 Apr; 23(2):8234-6.

View in: PubMed
Merandy K, Hardie T. Indicators of Health Literacy In Bladder Cancer Survivors: A Secondary Analysis of the Integrative Health Interview Series (IHIS). Urol Nurs. 2016 Jan-Feb; 36(1):37-43.

View in: PubMed
Winters BR, Bremjit PJ, Gore JL, Lin DW, Ellis WJ, Dalkin BL, Porter MP, Harper JD, Wright JL. Preliminary Comparative Effectiveness of Robotic Versus Open Radical Cystectomy in Elderly Patients. J Endourol. 2016 Feb; 30(2):212-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement